1031 / 1983
Treatment options
Surgery alone
EBRO
2017
30-40% potentially resectable
5-20% alive at 3-5 years
pN0 44-57% 5 year survival
pN1 13-15% 5 year survival
70% fail with distant metastases
A multimodality approach is necessary
to improve the poor results of surgery